OraSure Technologies Appoints Veteran Consumer Products Executive to Its Board of Directors
10 November 2011 - 10:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the
appointment of Gerald M. Ostrov as a member of the Company's Board
of Directors. Mr. Ostrov will serve as a Class I Director with an
initial term expiring in 2013.
"We are very pleased to welcome Gerald Ostrov, a highly
successful and seasoned healthcare executive, to our Board of
Directors," said Douglas G. Watson, Chairman of the Board of
OraSure Technologies. "Jerry has a long history of innovation and
success in the healthcare industry and his extensive expertise in
consumer packaged goods will be extremely valuable as we broaden
our product offerings in the over-the-counter market. We look
forward to Jerry's contributions to the Company's future
success."
Mr. Ostrov has a strong track record leading and innovating
global businesses in consumer products, medical device and
pharmaceutical industries. He most recently served as Chairman and
CEO of Bausch & Lomb from 2008 through 2010, where he
stabilized and restructured the business following its
privatization by private equity investors. During his tenure, Mr.
Ostrov focused on building a pipeline for the future while
improving profitability and cash flow.
Prior to this position, Mr. Ostrov spent the majority of his
career with Johnson & Johnson where he held the position of
Company Group Chairman responsible for the Worldwide Vision Care
businesses for nearly eight years, until his retirement in 2006. In
that capacity, Mr. Ostrov and his team delivered a consistent flow
of global product innovation which dramatically increased sales and
grew profitability even faster.
Mr. Ostrov began his career with Johnson & Johnson's Health
Care Division in 1976. In 1982, he left Johnson & Johnson
to become Vice President of Marketing for Ciba-Geigy's Consumer
Pharmaceuticals Company. He was named President of Ciba
Consumer Pharmaceuticals in 1985 and served in that capacity until
rejoining Johnson & Johnson in 1991 as President of the
corporation's Personal Products Company. In 1993, he was
promoted to Company Group Chairman and added Northern Europe
Consumer and Personal Care products to his
responsibilities. In 1995, he became responsible for all
Consumer and Personal Care businesses in North America. He
assumed Vision Care global responsibilities in 1998.
Mr. Ostrov's current focus is on consulting and developing new
technologies in the consumer products and consumer medical device
fields.
Mr. Ostrov earned his Bachelor of Science degree with
distinction in Industrial Engineering and Operations Research from
Cornell University and holds an M.B.A. from Harvard University.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. In
addition, through its wholly-owned subsidiary, DNA Genotek Inc.,
the Company also is a leading provider of oral fluid sample
collection, stabilization and preparation products for molecular
diagnostic applications. OraSure's portfolio of products is sold
globally to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, research and academic institutions, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. The Company's products enable healthcare
providers to deliver critical information to patients, empowering
them to make decisions to improve and protect their health. For
more information on OraSure Technologies, please visit
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: Investor Contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820
investorinfo@orasure.com
Media Contact:
Jennifer Moritz
Zer0 to 5ive for OraSure Technologies
917-748-4006
jmoritz@0to5.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024